Patent Yard Sign in
Canadian application, no grantCanada

Type 2 diabetes susceptibility genes

CA 2498476 A1 · Owner: Clee, Susanne M. · Inventors: Clee, Susanne M.; Stoehr, Jonathan P.; Schueler, Kathryn L.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Two of the genetic bases for susceptibility to type 2 diabetes are disclosed. The alleles of the genes SorCSI and SorCS3 that a person carries can determine whether or not that person is susceptible to type 2 diabetes.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 5, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 5, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 5, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 5, 2003
GrantedNo grant recorded
Term endedSeptember 5, 2023
Patent numberCA 2498476 A1
Classification (IPC)C12Q1/68 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedSep 5, 2003Term endedSep 5, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.